(Q45858873)

17 December 2017

title

Treatment of Hemophilia B with a New Clotting-Factor Concentrate (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

26 June 2023

0 references

0 references

M. S. Hoag

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5764825

26 June 2023

F. F. Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5764825

26 June 2023

J. A. Robinson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5764825

26 June 2023

P. M. Aggeler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5764825

26 June 2023

language of work or name

English

0 references

publication date

1 March 1969

1 reference

17 December 2017

full work available at URL

http://www.nejm.org/doi/pdf/10.1056/NEJM196903132801103

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

The New England Journal of Medicine

26 June 2023

published in

1 reference

17 December 2017

volume

280

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

581-586

1 reference

17 December 2017

Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Christmas disease: a condition previously mistaken for haemophilia

26 June 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Plasma thromboplastin component (PTC) potency of plasma fractions

26 June 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Purification of plasma thromboplastin factor B (plasma thromboplastin component) and its identification as a beta2 globulin

26 June 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.

26 June 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Clinical Use of Human Prothrombin Complexes

26 June 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

The Preparation for Therapeutic Use of a Concentrate of Factor IX Containing also Factors II, VII and X

26 June 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

26 June 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin

26 June 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Disappearance rate of concentrated proconvertin extracts in congenital and acquired hypoproconvertinemia

26 June 2023

34

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

The mechanism of clot dissolution by plasmin

26 June 2023

35

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Treatment of Hemophilia with Factor VIII Concentrates

26 June 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

Treatment of Hemophilia with Glycine-Precipitated Factor VIII

26 June 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM196903132801103

26 June 2023

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017